Audited Supplier
In This Store
| Polpharma API is a part of Polish leading multinational pharmaceutical group trusted by millions of patients and business partners for almost 90 years.
Polpharma API. Thanks to over 70 years of experience in process development, scale-up and cGMP manufacturing, we support both emerging and established pharmaceutical customers in the development and commercialization of their small molecule API clinical candidates. At our FDA-approved plant located in Central Europe, we provide end-to-end solutions from API development to scale-up allowing smooth process transfer for commercial-scale manufacturing capabilities, with world-class regulatory support. Our strong R&D management team, experienced in the development of chemical processes and complex projects, provides a wide range of solutions to our customers, applying a variety of chemical reactions and conditions, including cryogenic, High Pressure, strong base reactions, and tailor-made particle size distribution modifications. At Polpharma quality comes first. Regular FDA audits prove our reliability and credibility towards business partners around the world. Our team of highly qualified, skilled and enthusiastic experts combined with state-of-the-art equipment and facilities provides our partners with an outstanding customer experience. Polpharma API. Your European CDMO partner. |
Year of Establishment: 1935
Total Assets(USD):
Total Number of Staff: 100-500
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: ✅ 70 years of experience in API business ✅ Generics and CDMO From development to commercial ✅ Full value chain: R&D, Production, Supply Chain, PMO ✅ European location R&D and 2 manufacturing plants ✅ Agile organisation Fast decising making, top execution ✅ Project management excellence ✅ Global market presence
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight January 2025
